New 4-Serotype Dengue Fever Vaccine

Dengue, a mosquito-borne illness known for symptoms like fever,
headache, muscle pain and rash, poses a significant public health
challenge worldwide, particularly in Asia.

Our 4-Serotype Dengue Fever Vaccine offers a safe and effective
solution. It\'s suitable for individuals aged 4 to 60 years and requires
only two doses, administered three months apart. This advanced vaccine
surpasses its predecessor by accommodating a broader age range,
necessitating fewer doses and eliminating the need for prior dengue
history or blood tests.

The 4-Serotype Dengue Fever Vaccine is a valuable preventive measure,
especially for those at risk of dengue. It plays a crucial role in
reducing the risk of severe illness and mortality.

Vaccine Efficacy\*

Provides 80.2% protection against all four serotypes of dengue fever

Demonstrates 90.4% reduction in hospitalization rates

Achieves maximum immunity in 4 weeks and lasts at least 4-Â½ years after
the administration of the 2nd dose. (Reference: Supplementary Fig. S3.
Lancet Global Health 2024; 12: e257-70)

Vaccine Recommendations

Recommended for individuals aged 4-60

Suitable for individuals whether or not they have a prior history of
dengue fever; no blood test required for eligibility

Appropriate for individuals without underlying immune system disorders

Requires two doses, administered three months apart

Frequently Asked Questions (FAQ) regarding our New 4-Serotype Dengue
Fever Vaccine, click here.

Program Online Price

(THB) Promotion Price

(THB)

New 4-serotype Dengue Fever Vaccine for Ages 15 - 60 (2 doses) \| Buy
Now 4,700 4,800

6,550

Terms and Conditions

Price includes doctor's fees and hospital service fees

Promotions only available to Thai nationals and foreigners residing in
Thailand

Receive services at

Vaccine Center

Samitivej Sukhumvit Hospital

Samitivej Srinakarin Hospital

Available through December 31, 2024
